changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
London, UK, 15 July 2013
15 July 2013
COMPLETION OF ACQUISITION OF THERASPHERE®
On 23 May 2013, BTG plc (BTG), the specialist healthcare company, announced that it had entered into an agreement to buy the Targeted Therapies division of Nordion, Inc. (the Acquisition).
BTG is pleased to announce that completion of the Acquisition occurred on 13 July 2013 as planned.
BTG shareholders voted in favour of the Acquisition at the General Meeting on Thursday 11 July 2013.
Louise Makin – Chief Executive Officer +44 (0) 20 7575 0000
Rolf Soderstrom – Chief Financial Officer +44 (0) 20 7575 0000
Andy Burrows – Director of Investor Relations +44 (0) 20 7575 1741
FTI Consulting +44 (0)20 7831 3113
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com